Avacta Group (AVCT)

 

Latest News

Notice of Results

RNS Number: 0204Q Avacta Group PLC 07 September 2017 07 September 2017 Avacta Group plc ("Avacta", the "Group" or the "Company") Notice of Results Avacta Group plc (AIM: AVCT), the developer of Affimer biotherapeutics and research reagents, will announce its financial results for the year ended 31 July 2017 on Wednesday, 4 October 2017. Enquiries: Av...

Director Deals - Avacta Group PLC (AVCT)

Prof Alastair Smith, Chief Executive Officer, bought 33,225 shares in the company on the 21st August 2017 at a price of 74...

Director/PDMR Shareholding

RNS Number: 5552O Avacta Group PLC 21 August 2017 21 August 2017 Avacta Group plc ("Avacta", the "Group" or the "Company") Director/PDMR Shareholding Avacta Group plc (AIM: AVCT), the developer of Affimer biotherapeutics and research reagents, announces that its Chief Executive Officer, Dr Alastair Smith has today purchased 33,225 ordinary share...

Avacta revenues rise

Avacta Group expects revenues for the year ended 31 July to be 27% up on last time at 2.75m, in line with market forecasts...

All News

DateHeadlineSource
07-09-17Notice of ResultsRNS
21-08-17Director Deals - Avacta Group PLC (AVCT)StockMarketWire
21-08-17Director/PDMR ShareholdingRNS
07-08-17Avacta revenues rise StockMarketWire
07-08-17Trading UpdateRNS
31-07-17Issue of EquityRNS
28-07-17Director/PDMR ShareholdingRNS
05-07-17Director Dealing and Issue of EquityRNS
04-07-17Manchester ShareSoc Growth Company SeminarRNS
05-06-17ShareSoc Growth Company SeminarRNS
01-06-17Issue of EquityRNS
22-05-172 Biotech's Licence Affimers for Research UseRNS
10-05-17Avacta to be granted patent in China StockMarketWire
08-05-17Moderna releases Phase I trial data for mRNA technologyStockMarketWire
08-05-17Hardman Research: De-risking Moderna's partnershipRNS
05-05-17Avacta CEO to present at Hardman forum StockMarketWire
05-05-17Presenting at the Hardman Private Investor ForumRNS
02-05-17Avacta to Present at BioTrinity 2017RNS
24-04-17Avacta agrees exclusive deal with global diagnostics firm StockMarketWire
24-04-17Diagnostics firm take rights to several AffimersRNS
19-04-17Avacta to present at Shares Spotlight EveningStockMarketWire
19-04-17Avacta to Present at the Shares Spotlight EveningRNS
12-04-17Hardman Research: Another important box tickedRNS
06-04-17Holding(s) in CompanyRNS
06-04-17Holding(s) in CompanyRNS
06-04-17Director/PDMR ShareholdingRNS
05-04-17Avacta Plc to present at the Shares Spotlight Evening in London on 26 April 2017StockMarketWire
03-04-17Avacta revenues rise StockMarketWire
03-04-17Results of Immunogenicity Study with Human SamplesRNS
03-04-17Interim Results for the Period Ended 31 Jan 2017RNS
31-03-17Avacta Presents at Investor Evening Hosted by TPIRNS
31-03-17London Growth and Innovation Forum PresentationRNS
22-03-17Avacta CEO to present at UK Investor ShowStockMarketWire
22-03-17Avacta to present at the UK Investor ShowRNS
21-03-17Hardman Research: Low response would be positive!RNS
30-01-17Director/PDMR ShareholdingRNS
20-01-17Result of Annual General MeetingRNS
20-01-17Avacta sees substantial progress StockMarketWire
20-01-17Trading UpdateRNS
11-01-17Avacta CEO to present at London forum StockMarketWire

RSS feeds

  • Editorial news feed for LSE:AVCT Editorial
  • Regulatory news feed for LSE:AVCT Regulatory